Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma could profit from TCM regulation

This article was originally published in Scrip

Executive Summary

Some people regard Traditional Chinese Medicines as a haven of treatment for specific conditions when all else fails. Others believe that they are nothing short of a combination of witchcraft and deception. However, as the UK’s Department of Health contemplates regulating practitioners who dispense these products, the pharmaceutical industry would do well to take note. The move to introduce assessment and accreditation procedures into the TCM sector could produce both opportunities and challenges.

Topics

UsernamePublicRestriction

Register

SC007031

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel